Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cue Biopharma, Inc. - Common Stock (NQ:CUE)

0.7375 -0.0329 (-4.27%)
Streaming Delayed Price Updated: 3:58 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 202,412
Open 0.7652
Bid (Size) 0.7200 (10)
Ask (Size) 0.7704 (9)
Prev. Close 0.7704
Today's Range 0.7250 - 0.7654
52wk Range 0.5406 - 1.989
Shares Outstanding 44,959,548
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Cue Biopharma beats Q2 2025 revenue and EPS estimates, reports $2.95M revenue (-$0.09 EPS). Stock rises 2% amid FDA progress for CUE-401 autoimmune therapy. 
Via Chartmill

Performance

YTD
-32.3%
-32.3%
1 Month
+2.5%
+2.5%
3 Month
-10.1%
-10.1%
6 Month
-6.7%
-6.7%
1 Year
-58.6%
-58.6%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Discover the top movers in Monday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
What's Going On With Cue Biopharma Shares Tuesday?
Via Benzinga
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Announces Strategic Organizational Transition
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
From Cue Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Cue Biopharma, Inc. - Common Stock publicly traded?
Yes, Cue Biopharma, Inc. - Common Stock is publicly traded.
What exchange does Cue Biopharma, Inc. - Common Stock trade on?
Cue Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cue Biopharma, Inc. - Common Stock?
The ticker symbol for Cue Biopharma, Inc. - Common Stock is CUE on the Nasdaq Stock Market
What is the current price of Cue Biopharma, Inc. - Common Stock?
The current price of Cue Biopharma, Inc. - Common Stock is 0.7375
When was Cue Biopharma, Inc. - Common Stock last traded?
The last trade of Cue Biopharma, Inc. - Common Stock was at 10/28/25 03:58 PM ET
What is the market capitalization of Cue Biopharma, Inc. - Common Stock?
The market capitalization of Cue Biopharma, Inc. - Common Stock is 33.16M
How many shares of Cue Biopharma, Inc. - Common Stock are outstanding?
Cue Biopharma, Inc. - Common Stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.